Equilabium glandulosum
Equilabium glandulosum · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Equilabium glandulosum is a botanical species that has garnered scientific interest due to its potential therapeutic activities. Research focusing on the plant's leaves has specifically highlighted its antithrombotic properties. Various preparations, including aqueous extracts, hydro-ethanolic extracts, and ethyl acetate fractions, have been utilized to study its chemical profile. These studies aim to evaluate the plant's impact on critical metabolic markers such as cholesterol esterase and triglycerides. Consequently, these fractions provide a foundation for understanding the medicinal potential of this plant in managing cardiovascular health.
- Synonyms
- Plectranthus Glandulosus · Plectranthus Urticoides · 3 more
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Equilabium glandulosum is a botanical subject that is frequently identified by several different scientific names. Throughout various taxonomic studies, this plant has been closely associated with several synonyms within the Plectranthus genus. Specifically, researchers have historically referred to it as Plectranthus almamii and Plectranthus glandulosus. Other recognized variations include the names Plectranthus hylophilus and Plectranthus phryxotrichus. Finally, the species is also documented under the synonym Plectranthus urticoides, illustrating the complex naming history of the plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Equilabium glandulosum is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further belongs to the order Lamiales, which defines many of its structural characteristics. As a member of the genus Equilabium, it occupies a distinct niche in its natural environment. Finally, its specific biological placement is solidified within the family Lamiaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Equilabium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Equilabium glandulosum is a plant species primarily found throughout the diverse landscapes of Africa. Its geographic range spans the East Tropical Africa region, including specific populations in Kenya, Tanzania, and Uganda. Additionally, the species extends into Northeast Tropical Africa, where it can be located in Ethiopia. The distribution also encompasses the territories of Sudan and South Sudan. This broad presence across these various nations highlights the plant's significant ecological footprint within the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Equilabium glandulosum is a self-supporting herb characterized by its distinct growth form. This plant reaches a maximum height of approximately 3.05 meters as it matures. Its structural stability allows it to thrive effectively within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Equilabium glandulosum, also known as Plectranthus glandulosus, has demonstrated significant antithrombotic activity in recent laboratory studies. Researchers investigated various leaf extracts and fractions to determine their effectiveness in inhibiting blood clotting mechanisms. The findings revealed that the ethyl acetate fraction exhibited the strongest antithrombotic performance across all tested concentrations. While these results did not match the efficacy of the standard drug aspirin, the hydroethanolic extract also showed promising activity among the crude extracts. Ultimately, these properties suggest that the plant could serve as a valuable natural source for the development of future antiatherosclerotic medications.
Compounds
Conditions
Equilabium glandulosum (identified as Plectranthus glandulosus in the studies) demonstrates significant therapeutic potential by decreasing LDL-C levels through the use of ethyl acetate fractions. The plant also shows safety in medical applications, as it exhibits no acute oral toxicity in tested subjects. Research indicates that its hydroethanolic extract effectively treats adipocytes lipid uptake by inhibiting lipid absorption. Furthermore, the ethyl acetate fraction provides beneficial antithrombotic activity across various concentrations. Finally, the plant aids in cardiovascular health by providing aorta media thickening attenuation in high-fat diet models.
Preparations
Equilabium glandulosum is prepared as aqueous extract, hydro-ethanolic extract, and ethyl acetate fraction for various toxicological and pharmacological evaluations. The plant is also processed into leaves extracts to investigate its antilipidic and antithrombotic activities. Research involves the use of specific fractions derived from these preparations to measure their inhibitory effects on enzymes like pancreatic lipase. Through these different preparation methods, the biological properties and safety profiles of the plant are thoroughly examined.
Parts used
Equilabium glandulosum, also referred to in botanical studies as Plectranthus glandulosus, possesses leaves that serve as a primary source of bioactive compounds. Research indicates that extracts derived from these leaves exhibit significant antilipidic and antithrombotic activities. Specifically, the hydroethanolic and ethyl acetate fractions of the leaves have demonstrated the ability to inhibit pancreatic lipase and cholesterol esterase. In vivo studies further suggest that these leaf extracts can regulate lipid profiles and reduce oxidative stress in animal models. Consequently, the medicinal properties found within the leaves highlight the plant's potential for future anti-atherosclerotic drug discovery.